{
    "2019-05-07": [
        [
            {
                "time": "",
                "original_text": "【国金研究】生物制品行业2018年报2019一季报总结及批签发分析",
                "features": {
                    "keywords": [
                        "生物制品",
                        "2018年报",
                        "2019一季报",
                        "批签发"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药】2018年报及2019年一季报综述:轻装上阵、2019有望前低后高、重视商业板块*强于大市",
                "features": {
                    "keywords": [
                        "医药",
                        "2018年报",
                        "2019一季报",
                        "轻装上阵",
                        "前低后高",
                        "商业板块"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "商业板块"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}